{
    "2021-07-28": [
        [
            {
                "time": "",
                "original_text": "欧普康视(300595.SZ)：南京欧陶拟参与转融通出借业务 参与股份不超1701.3439万股",
                "features": {
                    "keywords": [
                        "欧普康视",
                        "南京欧陶",
                        "转融通",
                        "出借业务",
                        "1701.3439万股"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "欧普康视(300595.SZ)主要股东南京欧陶拟参与转融通证券出借业务",
                "features": {
                    "keywords": [
                        "欧普康视",
                        "南京欧陶",
                        "转融通",
                        "证券出借"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "欧普康视：南京欧陶拟公司2%股份参与转融通出借业务计划",
                "features": {
                    "keywords": [
                        "欧普康视",
                        "南京欧陶",
                        "2%股份",
                        "转融通",
                        "出借业务"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业2021年中期投资策略：掘金少儿经济、银发经济与创新国际化",
                "features": {
                    "keywords": [
                        "医药生物",
                        "投资策略",
                        "少儿经济",
                        "银发经济",
                        "创新国际化"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}